Trials / Completed
CompletedNCT02743234
Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Randomized open label clinical trial to compare the clinical and microbiological efficacy of fecal microbiota transplantation, fidaxomicin, and vancomycin for relapsing Clostridium difficile infection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fecal microbiota transplantation | FMT follows 4-10 days of vancomycin 125 mg x 4 daily |
| DRUG | Fidaxomicin | Fidaxomicin 200 mg x 2 daily for 10 days |
| DRUG | Vancomycin | Vancomycin 125 mg x 4 daily for 10 days |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2019-02-01
- Completion
- 2019-08-31
- First posted
- 2016-04-19
- Last updated
- 2019-10-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02743234. Inclusion in this directory is not an endorsement.